Browse > Article
http://dx.doi.org/10.6116/kjh.2018.33.6.9.

Interactions between herbal medicines and synthetic antihypertensive drugs  

Oh, Yoona (Division of Pharmacology, School of Korean Medicine, Pusan National University)
Lee, Hongbum (Division of Pharmacology, School of Korean Medicine, Pusan National University)
Kim, Hyungwoo (Division of Pharmacology, School of Korean Medicine, Pusan National University)
Publication Information
The Korea Journal of Herbology / v.33, no.6, 2018 , pp. 9-18 More about this Journal
Abstract
Objective : Many patients take antihypertensive drugs as well as herbal medicines at the same time in order to treat other symptoms or to keep their well-being. In this study, interactions between herbal medicines and synthetic antihypertensive drugs were analyzed. Methods : To investigate the interaction between herbal medicines and synthetic antihypertensive drugs, three electronic databases, including OASIS, Mediline and Sciencedirect were searched. Experimental and clinical studies on the interaction between herbal medicines and antihypertensive drugs were independently reviewed and included. Results : Analyzing selected studies, twenty herbs were found to interact with antihypertensive drugs. Herbs found to increase the antihypertensive effect were Panax ginseng, Carthamus tinctorius, Magnolia officinalis, Silybum marianum, Scutellaria baicalensis, Schisandra chinensis, Sophora flavescens, Piper nigrum, Curcuma longa, Ginkgo biloba, Juncus effuses and Hydrastis canadensis. In contrast, Commiphora myrrha, Rhodiola rosea, Hypericum perforatum, Eurycoma longifolia, and Daturae metel were found to inhibit the antihypertensive effect. Stephania tetrandra could increase or decrease the effect depending on the type of antihypertensive drug. Epedria sínica was suspected of pharmacodynamic interaction with antihypertensive drug. Glycyrrhiza uralensis has been reported to have serious side effects in combination with antihypertensive drugs. Conclusion : These results imply that when used in combination with herbal medicines and synthetic antihypertensive drugs, proper doses and herbs which are to avoid need to be informed to the patients. Despite concerns about interactions between herbal medicines and synthetic drugs, related research is very limited. More systematic researches are needed to give information on patient safety as well as to guide clinical practice.
Keywords
Herbal medicine; Antihypertensive drug; Herb-drug interaction; Safety;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Lv QL, Wang GH, Chen SH, Hu L, Zhang X, Ying G, Qin CZ, Zhou HH. In vitro and in vivo inhibitory effects of glycyrrhetinic acid in mice and human cytochrome P450 3A4. Int J Environ Res Public Health. 2015 ; 13(1) :84.   DOI
2 Cumming AM, Boddy K, Brown JJ, Fraser R, Lever AF, Padfield PL, Robertson JI. Severe hypokalaemia with paralysis induced by small doses of liquorice. Postgrad Med J. 1980 ; 56(657) : 526-529.   DOI
3 King VF, Garcia ML, Himmel D, Reuben JP, Lam YK, Pan JX, Han GQ, Kaczorowski GJ. Interaction of tetrandrine with slowly inactivating calcium channels. Characterization of calcium channel modulation by an alkaloid of Chinese medicinal herb origin. J Biol Chem. 1988 ; 263(5) : 2238-2244.
4 Liu G, Liu Y, Liu R, Dong F, Zhang Z. Effects of flos carthami on CYP2D6 and on the pharmacokinetics of metoprolol in rats. Evid Based Complement Alternat Med. 2011 ; 2011: 207076.
5 Ulbricht C, Basch E, Szapary P, Hammerness P, Axentsev S, Boon H, Kroll D, Garraway L, Vora M, Woods J. Guggul for hyperlipidemia: a review by the natural standard research collaboration. Complement Ther Med. 2005 ; 13(4) : 279-290.   DOI
6 Dalvi SS, Nayak VK, Pohujani SM, Desai NK, Kshirsagar NA, Gupta KC. Effect of gugulipid on bioavailability of diltiazem and propranolol. J Assoc Physicians India. 1994 ; 42(6) : 454-455.
7 Jeong HU, Kong TY, Kwon SS, Hong SW, Yeon SH , Choi JH, Lee JY, Cho YY, Lee HS. Effect of honokiol on cytochrome P450 and UDP-glucuronosyltransferase enzyme activities in human liver microsomes. Molecules. 2013 ; 18(9) : 10681-10693.   DOI
8 Han Y, Guo D, Chen Y, Chen Y, Tan ZR, Zhou HH. Effect of silymarin on the pharmacokinetics of losartan and its active metabolite E-3174 in healthy Chinese volunteers. Eur J Clin Pharmacol. 2009 ; 65(6) : 585-591.   DOI
9 Han Y, Guo D, Chen Y, Tan ZR, Zhou HH. Effect of continuous silymarin administration on oral talinolol pharmacokinetics in healthy volunteers. Xenobiotica. 2009 ; 39(9) : 694-699.   DOI
10 Doehmer J, Weiss G, McGregor GP, Appel K. Assessment of a dry extract from milk thistle (Silybum marianum) for interference with human liver cytochrome-P450 activities. Toxicol In Vitro. 2011 ; 25(1) : 21-27.   DOI
11 Fuhr U, Beckmann-Knopp S, Jetter A, Luck H, Mengs U. The effect of silymarin on oral nifedipine pharmacokinetics. Planta Med. 2007 ; 73(14) : 1429-1435.   DOI
12 Zuber R, Modriansky M, Dvorak Z, Rohovsky P, Ulrichova J, Simanek V, Anzenbacher P. Effect of silybin and its congeners on human liver microsomal cytochrome P450 activities. Phytother Res. 2002 ; 16(7) : 632-638.   DOI
13 Yi S, Cho JY, Lim KS, Kim KP, Kim J, Kim BH, Hong JH, Jang IJ, Shin SG, Yu KS. Effects of Angelicae tenuissima radix, Angelicae dahuricae radix and Scutellariae radix extracts on cytochrome P450 activities in healthy volunteers. Basic Clin Pharmacol Toxicol. 2009 ; 105(4) : 249-256.   DOI
14 Fan L, Mao XQ, Tao GY, Wang G, Jiang F, Chen Y, Li Q, Zhang W, Lei HP, Hu DL, Huang YF, Wang D, Zhou HH. Effect of Schisandra chinensis extract and Ginkgo biloba extract on the pharmacokinetics of talinolol in healthy volunteers. Xenobiotica. 2009 ; 39(3) : 249-254.   DOI
15 Yuan F, Chen J, Wu WJ, Chen SZ, Wnag XD, Su Z, Huang M. Effects of matrine and oxymatrine on catalytic activity of cytochrome p450s in rats. Basic Clin Pharmacol Toxicol. 2010 ; 107(5) : 906-913.   DOI
16 Bano G, Raina RK, Zutshi U, Bedi KL, Johri RK, Sharma SC. Effect of piperine on bioavailability and pharmacokinetics of propranolol and theophylline in healthy volunteers. Eur J Clin Pharmacol. 1991 ; 41(6) : 615-617.   DOI
17 Wei YL, Du HJ, Lin YP, Wu ML, Xu RA. Effects of salidroside on rat CYP enzymes by a cocktail of probe drugs. Iran J Basic Med Sci. 2018 ; 21(4) : 422-426.
18 Liu AC, Zhao LX, Xing J, Liu T, Du FY, Lou HX. Pre-treatment with curcumin enhances plasma concentrations of losartan and its metabolite EXP3174 in rats. Biol Pharm Bull. 2012 ; 35(2) : 145-150.   DOI
19 Noriaki O, Mayako K, Mutsunobu Y, Kazuo K, Akihiro S, Fumi N, Tomokazu K, Masato N, Satoshi H, Tsuyoshi M, Masayuki Y, Shunsaku O, Koji T, Teruyoshi Y. Studies on Interactions between Functional Foods or Dietary Supplements and Medicines. I. Effects of Ginkgo biloba Leaf Extract on the Pharmacokinetics of Diltiazem in Rats. Biological and Pharmaceutical Bulletin 2003 ; 26(9) : 1315-1321.   DOI
20 G. Zadoyan, D. Rokitta, S. Klement, A. Dienel, R. Hoerr, T. Gramatte U. Fuhr. Effect of Ginkgo biloba special extract EGb 761(R) on human cytochrome P450 activity: a cocktail interaction study in healthy volunteers. Eur J Clin Pharmacol 2012 ; 68: 553-560.   DOI
21 Lu H, Lu Z, Li X, Li G, Qiao Y, Borris RP, Zhang Y. Interactions of 172 plant extracts with human organic anion transporter 1 (SLC22A6) and 3 (SLC22A8): a study on herb-drug interactions. PeerJ. 2017 ; 5 : e3333.   DOI
22 Gurley BJ, Fifer EK, Gardner Z. Pharmacokinetic herb-drug interactions (part 2): drug interactions involving popular botanical dietary supplements and their clinical relevance. Planta Med. 2012 ; 78(13) : 1490-1514.   DOI
23 Di YM, Li CG, Xue CC, Zhou SF. Clinical Drugs that Interact with St. John's Wort and mplication in Drug Development. Current Pharmaceutical Design. 2008 ; 14(17) : 1723-1742.   DOI
24 Schwarz UI, Hanso H, Oertel R, Miehlke S, Kuhlisch E, Glaeser H, Hitzl M, Dresser GK, Kim RB, Kirch W. Induction of intestinal P-glycoprotein by St John's wort reduces the oral bioavailability of talinolol. Clin Pharmacol Ther. 2007 ; 81(5) : 669-678.   DOI
25 Markert C, Kastner IM, Hellwig R, Kalafut P, Schweizer Y, Hoffmann MM, Burhenne J, Weiss J, Mikus G, Haefeli WE. The effect of induction of CYP3A4 by St John's wort on ambrisentan plasma pharmacokinetics in volunteers of known CYP2C19 genotype. Basic Clin Pharmacol Toxicol. 2015 ; 116(5) : 423-428.   DOI
26 Tannergren C, Engman H, Knutson L, Hedeland M, Bondesson U, Lennernas H. St John's wort decreases the bioavailability of R- and S-verapamil through induction of the first-pass metabolism. clinical pharmacology and therapeutics. 2000 ; 75(4) : 298-309.   DOI
27 Wang XD, Li JL, Lu Y, Chen X, Huang M, Chowbay B, Zhou SF. Rapid and simultaneous determination of nifedipine and dehydronifedipine in human plasma by liquid chromatography-tandem mass spectrometry: Application to a clinical herb-drug interaction study. J Chromatogr B Analyt Technol Biomed Life Sci. 2007 ; 852(1-2) : 534-544.   DOI
28 Gurley BJ, Gardner SF, Hubbard MA, Williams DK, Gentry WB, Cui Y, Ang CY. Cytochrome P450 phenotypic ratios for predicting herb-drug interactions in humans. Clin Pharmacol Ther. 2002 ; 72(3) : 276-287.   DOI
29 Gurley BJ, Gardner SF, Hubbard MA, Williams DK, Gentry WB, Khan IA, Shah A. In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4/5 phenotypes. Clin Pharmacol Ther. 2005 ; 77(5) : 415-426.   DOI
30 Gurley BJ, Swain A, Hubbard MA, Williams DK, Barone G, Hartsfield F, Tong Y, Carrier DJ, Cheboyina S, Battu SK. Clinical assessment of CYP2D6-mediated herb-drug interactions in humans: effects of milk thistle, black cohosh, goldenseal, kava kava, St. John's wort, and Echinacea. Mol Nutr Food Res. 2008 ; 52(7) : 755-763.   DOI
31 Kim DS, Goo YM, Cho J, Lee J, Lee DY, Sin SM, Kil YS, Jeong WM, Ko KH, Yang KJ, Kim YG, Kim SG, Kim K, Kim YJ, Kim JK, Shin EC. Effect of volatile organic chemicals in chrysanthemum indicum linne on blood pressure and electroencephalogram. Molecules. 2018 ; 23(8).
32 SAB Salman, S Amrah, MSA Wahab, Z Ismail, R Ismail, KH Yuen, SH Gan. Modification of propranolol’s bioavailability by Eurycoma longifolia water-based extract. Journal of Clinical Pharmacy and Therapeutics. 2010 ; 35 : 691-696.   DOI
33 Geng P, Wang S, Wang C, Chen J, Zhang L, Yang S, Wen C, Zhou Y, Zhang M. Evaluation of the impact of Flos Daturae on rat hepatic cytochrome P450 enzymes by cocktail probe drugs. Int J Clin Exp Med. 2015 ; 8(12) : 22310-22318.
34 Yang CS, Kim YE, Kim IT, Kim C, Yea SJ, Song MY. Developing a Database of Herb-Drug Interaction on Hypertension. Integrative medicine research. 2015 ; 4(1) : 142.
35 World Health Organization. Global health risks - mortality and burden of disease attributable to selected major risks. 2009 : 11-12.
36 The ministry of health and welfare. Korean statistical information service. Available from URL: http://kosis.kr/
37 The korean society of hypertension. Korea hypertension fact sheet. 2018 : 6-18.
38 Korean academy of medical sciences. Evidence-based recommendations for hypertension in primary care. 2018 : 71-72.
39 Xinke Z, Yingdong L, Mingxia F, Kai L, Kaibing C, Yuqing L. Shaobo S, Peng S, Bin L. Chinese herbal medicine for the treatment of primary hypertension: a methodology overview of systematic reviews. Syst Rev. 2016 ; 5(1) : 180.   DOI
40 Wang P, Xiong X, Li S. Efficacy and safety of a traditional chinese herbal formula xuefu zhuyu decoction for hypertension: a systematic review and meta-analysis. Medicine(Baltimore). 2015 ; 94(42) : e1850.   DOI
41 Gupta RC, Chang D, Nammi S, Bensoussan A, Bilinski K, Roufogalis BD. Interactions between antidiabetic drugs and herbs: an overview of mechanisms of action and clinical implications. Diabetoloy &Metabolic Syndrome. 2017 ; 9 : 59-71   DOI
42 Zisaki A, Miskovic L, Hatzimanikatis V. Antihypertensive drugs metabolism: an update to pharmacokinetic profiles and computational approaches. Curr Pharm Des. 2015 ; 21(6) : 806-822.
43 Kim CM, Shin GM, An DG, Lee KS. The encyclopedia of oriental herbal medicine. Seoul, South Korea : Jeongdam. 1997.
44 Mills E, Montori VM, Wu P, Gallicano K, Clarke M, Guyatt G. Interaction of St John's wort with conventional drugs: systematic review of clinical trials. BMJ. 2004 ; 329(7456): 27-30.   DOI
45 Guozhen H. Chinese medicine pharmacology. 2008.
46 Persky AM, Berry NS, Pollack GM, Brouwer KL. Modelling the cardiovascular effects of ephedrine. Br J Clin Pharmacol. 2004 ; 57(5) : 552-562.   DOI
47 Gurley BJ, Gardner SF, Hubbard MA, Williams DK, Gentry WB, Cui Y, Ang CY. Clinical assessment of effects of botanical supplementation on cytochrome P450 phenotypes in the elderly: St John's wort, garlic oil, Panax ginseng and Ginkgo biloba. Drugs Aging. 2005 ; 22(6) : 525-539.   DOI
48 Liang Y, Zhou Y, Zhang J, Rao T, Zhou R, Wang Q, Fu H, Hao K, Xie L, Wang G. Pharmacokinetic compatibility of ginsenosides and Schisandra Lignans in Shengmai-san: from the perspective of p-g lycoprotein. PLoS One. 2014 ; 9(6) : e98717.   DOI
49 Haller CA, Benowitz NL. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. N Engl J Med. 2000 ; 343(25) : 1833-1838.   DOI
50 Kuhn MA. Herbal remedies: drug-herb interactions. Crit Care Nurse. 2002 ; 22(2):22-28,30,32.
51 Jia JJ, Zeng XS, Li Y, Ma S, Bai J. Ephedrine induced thioredoxin-1 expression through beta-adrenergic receptor/cyclic AMP/protein kinase A/dopamine and cyclic AMP-regulated phosphoprotein signaling pathway. Cell Signal. 2013 ; 25(5) : 1194-1201.   DOI